#8444. A randomized, active-controlled, multicentre clinical trial to evaluate the efficacy and safety of oral sitafloxacin versus levofloxacin in Chinese adults with acute uncomplicated or complicated urinary tract infection

November 2026publication date
Proposal available till 30-05-2025
4 total number of authors per manuscript4500 $

The title of the journal is available only for the authors who have already paid for
Journal’s subject area:
Medicine (all);
Places in the authors’ list:
place 1place 2place 3place 4
FreeFreeFreeFree
1350 $1200 $1050 $900 $
Contract №8444.1 Contract №8444.2 Contract №8444.3 Contract №8444.4
1 place - free (for sale)
2 place - free (for sale)
3 place - free (for sale)
4 place - free (for sale)

Abstract:
We evaluate the efficacy and safety of oral sitafloxacin versus levofloxacin in patients with acute urinary tract infections (UTIs). Findings at test-of-cure (TOC) visit revealed that oral sitafloxacin was as effective and safe as levofloxacin. It showed similar clinical cure rate and bacterial eradication rate. Hence, it can serve as a promising alternative treatment option.
Keywords:
efficacy; levofloxacin; randomized controlled trial; safety; Sitafloxacin; urinary tract infection

Contacts :
0